Literature DB >> 24982816

Cyclotron production of (68)Ga via the (68)Zn(p,n)(68)Ga reaction in aqueous solution.

Mukesh K Pandey1, John F Byrne2, Huailei Jiang1, Alan B Packard3, Timothy R DeGrado1.   

Abstract

The objective of the present work is to extend the applicability of the solution target approach to the production of (68)Ga using a low energy cyclotron. Since the developed method does not require solid target infrastructure, it offers a convenient alternative to (68)Ge/(68)Ga generators for the routine production of (68)Ga. A new solution target with enhanced heat exchange capacity was designed and utilized with dual foils of Al (0.20 mm) and Havar (0.038 mm) separated by helium cooling to degrade the proton energy to ~14 MeV. The water-cooled solution target insert was made of Ta and its solution holding capacity (1.6 mL) was reduced to enhance heat transfer. An isotopically enriched (99.23%) 1.7 M solution of (68)Zn nitrate in 0.2 N nitric acid was utilized in a closed target system. After a 30 min irradiation at 20 μA, the target solution was unloaded to a receiving vessel and the target was rinsed with 1.6 mL water, which was combined with the target solution. An automated module was used to pass the solution through a cation-exchange column (AG-50W-X8, 200-400 mesh, hydrogen form) which efficiently trapped zinc and gallium isotopes. (68)Zn was subsequently eluted with 30 mL of 0.5 N HBr formulated in 80% acetone without any measurable loss of (68)Ga. (68)Ga was eluted with 7 mL of 3 N HCl solution with 92-96% elution efficiency. The radionuclidic purity was determined using an HPGe detector. Additionally, ICP-MS was employed to analyze for non-radioactive metal contaminants. The product yield was 192.5 ± 11.0 MBq/μ·h decay-corrected to EOB with a total processing time of 60-80 min. The radionuclidic purity of (68)Ga was found to be >99.9%, with the predominant contaminant being 67Ga. The ICP-MS analysis showed small quantities of Ga, Fe, Cu, Ni and Zn in the final product, with (68)Ga specific activity of 5.20-6.27 GBq/μg. Depending upon the user requirements, (68)Ga production yield can be further enhanced by increasing the (68)Zn concentration in the target solution and extending the irradiation time. In summary, a simple and efficient method of (68)Ga production was developed using low energy cyclotron and a solution target. The developed methodology offers a cost-effective alternative to the (68)Ge/(68)Ga generators for the production of (68)Ga.

Entities:  

Keywords:  68Ga; cyclotron targetry; solution target

Year:  2014        PMID: 24982816      PMCID: PMC4074496     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  14 in total

1.  Gallium-68 somatostatin receptor PET/CT: is it time to replace (111)Indium DTPA octreotide for patients with neuroendocrine tumors?

Authors:  Kjell Öberg
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

2.  Generator breakthrough and radionuclidic purification in automated synthesis of 68Ga-DOTANOC.

Authors:  Francesca Belosi; Gianfranco Cicoria; Filippo Lodi; Claudio Malizia; Stefano Fanti; Stefano Boschi; Mario Marengo
Journal:  Curr Radiopharm       Date:  2013-06-06

3.  Current status and future needs for standards of radionuclides used in positron emission tomography.

Authors:  B E Zimmerman
Journal:  Appl Radiat Isot       Date:  2012-09-23       Impact factor: 1.513

4.  Past, present and future of 68Ge/68Ga generators.

Authors:  F Rösch
Journal:  Appl Radiat Isot       Date:  2012-11-22       Impact factor: 1.513

5.  Production of 89Zr via the 89Y(p,n)89Zr reaction in aqueous solution: effect of solution composition on in-target chemistry.

Authors:  Mukesh K Pandey; Hendrik P Engelbrecht; John P Byrne; Alan B Packard; Timothy R DeGrado
Journal:  Nucl Med Biol       Date:  2014-01-17       Impact factor: 2.408

6.  Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours.

Authors:  Nils F Schreiter; Winfried Brenner; Munenobu Nogami; Ralph Buchert; Alexander Huppertz; Ulrich-Frank Pape; Vikas Prasad; Bernd Hamm; Martin H Maurer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-17       Impact factor: 9.236

7.  Very high specific activity ⁶⁶/⁶⁸Ga from zinc targets for PET.

Authors:  J W Engle; V Lopez-Rodriguez; R E Gaspar-Carcamo; H F Valdovinos; M Valle-Gonzalez; F Trejo-Ballado; G W Severin; T E Barnhart; R J Nickles; M A Avila-Rodriguez
Journal:  Appl Radiat Isot       Date:  2012-03-28       Impact factor: 1.513

Review 8.  Clinical applications of Gallium-68.

Authors:  Sangeeta Ray Banerjee; Martin G Pomper
Journal:  Appl Radiat Isot       Date:  2013-02-20       Impact factor: 1.513

9.  THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience.

Authors:  Richard P Baum; Harshad R Kulkarni
Journal:  Theranostics       Date:  2012-05-07       Impact factor: 11.556

Review 10.  Prospective of ⁶⁸Ga-radiopharmaceutical development.

Authors:  Irina Velikyan
Journal:  Theranostics       Date:  2013-12-10       Impact factor: 11.556

View more
  17 in total

Review 1.  Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications.

Authors:  Thomas A Hope; Ali Afshar-Oromieh; Matthias Eiber; Louise Emmett; Wolfgang P Fendler; Courtney Lawhn-Heath; Steven P Rowe
Journal:  AJR Am J Roentgenol       Date:  2018-06-27       Impact factor: 3.959

Review 2.  Production of radiometals in liquid targets.

Authors:  Sergio J C do Carmo; Peter J H Scott; Francisco Alves
Journal:  EJNMMI Radiopharm Chem       Date:  2020-01-10

3.  18F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer.

Authors:  Christos Sachpekidis; A Afshar-Oromieh; K Kopka; D S Strauss; L Pan; U Haberkorn; A Dimitrakopoulou-Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-14       Impact factor: 9.236

Review 4.  Good practices for 68Ga radiopharmaceutical production.

Authors:  Bryce J B Nelson; Jan D Andersson; Frank Wuest; Sarah Spreckelmeyer
Journal:  EJNMMI Radiopharm Chem       Date:  2022-10-22

5.  ImmunoPET: Concept, Design, and Applications.

Authors:  Weijun Wei; Zachary T Rosenkrans; Jianjun Liu; Gang Huang; Quan-Yong Luo; Weibo Cai
Journal:  Chem Rev       Date:  2020-03-23       Impact factor: 60.622

6.  Radiosynthesis of [18F]SiFAlin-TATE for clinical neuroendocrine tumor positron emission tomography.

Authors:  Simon Lindner; Carmen Wängler; Björn Wängler; Ralf Schirrmacher; Justin J Bailey; Klaus Jurkschat; Peter Bartenstein
Journal:  Nat Protoc       Date:  2020-11-23       Impact factor: 13.491

7.  Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119

Authors:  Parmissa Randhawa; Aeli P Olson; Shaohuang Chen; Kaley Lexi Gower-Fry; Cornelia Hoehr; Jonathan W Engle; Caterina F Ramogida; Valery Radchenko
Journal:  Curr Radiopharm       Date:  2021

Review 8.  Production of novel diagnostic radionuclides in small medical cyclotrons.

Authors:  Mateusz Adam Synowiecki; Lars Rutger Perk; J Frank W Nijsen
Journal:  EJNMMI Radiopharm Chem       Date:  2018-02-20

Review 9.  Current status of theranostics in prostate cancer.

Authors:  Irene Virgolini; Clemens Decristoforo; Alexander Haug; Stefano Fanti; Christian Uprimny
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-28       Impact factor: 9.236

10.  Interdisciplinary Tasks in the Cyclotron Production of Radiometals for Medical Applications. The Case of 47Sc as Example.

Authors:  Alessandra Boschi; Petra Martini; Valentina Costa; Antonella Pagnoni; Licia Uccelli
Journal:  Molecules       Date:  2019-01-26       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.